Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2026-07-22 16:30:25 ET · period of report 2026-07-21 · accession 0001493152-26-034246 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-22 16:30 | 2026-07-21 | ABEO | Vazzano Joseph Walter | CFO | S - Sale | $6.53 | -1,478 | 492.1K | -0.3% | -$9,651 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-21 | S | D | 1,478 | $6.53 | 492,079 | D | — | — | (F1) Represents shares withheld to satisfy tax withholding obligations upon vesting of restricted stock awards. |